We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$508M
AUM Growth
+$11.3M
Cap. Flow
+$5.18M
Cap. Flow %
1.02%
Top 10 Hldgs %
26.12%
Holding
122
New
10
Increased
33
Reduced
37
Closed
13

Top Buys

Rank Stock Value
1
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$6.03M
2
CINC
CinCor Pharma, Inc. Common Stock
CINC
+$5.53M
3
SPRY icon
ARS Pharmaceuticals
SPRY
+$5.15M
4
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$5.12M
5
IRTC icon
iRhythm Holdings
IRTC
+$4.03M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$9.2M
2
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$6.77M
3
TNDM icon
Tandem Diabetes Care
TNDM
+$6.26M
4
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$4.85M
5
CNVY
Convey Health Solutions Holdings, Inc.
CNVY
+$4.16M

Sector Composition

Rank Sector Weight
1 Healthcare 95.94%
2 Industrials 4.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DHR icon
76
Danaher
DHR
$139B
$2.23M 0.44%
9,729
– –
CI icon
77
Cigna
CI
$74.5B
$2.16M 0.43%
7,800
– –
MRNA icon
78
Moderna
MRNA
$21.9B
$2.16M 0.43%
18,293
+200
+1% +$30.3K
SYK icon
79
Stryker
SYK
$131B
$2.11M 0.41%
+10,400
New +$2.19M
MOH icon
80
Molina Healthcare
MOH
$10.2B
$2.07M 0.41%
6,275
-4,000
-39% -$1.29M
ELV icon
81
Elevance Health
ELV
$83B
$1.93M 0.38%
4,250
-1,250
-23% -$598K
EFTR
82
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$1.36M 0.27%
95,306
– –
ZNTL icon
83
Zentalis Pharmaceuticals
ZNTL
$331M
$1.3M 0.26%
+60,000
New +$1.64M
AZN icon
84
AstraZeneca
AZN
$245B
$1.07M 0.21%
9,755
+1,550
+19% +$197K
ILMN icon
85
Illumina
ILMN
$30B
$881K 0.17%
4,749
+1,233
+35% +$244K
OM icon
86
Outset Medical
OM
$92.5M
$797K 0.16%
+3,333
New +$892K
ONC
87
BeOne Medicines Ltd
ONC
$32.6B
$779K 0.15%
5,780
+700
+14% +$120K
RPRX icon
88
Royalty Pharma
RPRX
$25.3B
$488K 0.1%
12,140
-1,700
-12% -$72.6K
ZLAB icon
89
Zai Lab
ZLAB
$2.05B
$479K 0.09%
14,000
– –
INCY icon
90
Incyte
INCY
$24B
$472K 0.09%
7,080
– –
RDY icon
91
Dr. Reddy's Laboratories
RDY
$10.1B
$471K 0.09%
45,020
+2,500
+6% +$26.6K
ARGX icon
92
argenx
ARGX
$52B
$448K 0.09%
1,270
– –
UTHR icon
93
United Therapeutics
UTHR
$25.7B
$401K 0.08%
1,915
– –
LEGN icon
94
Legend Biotech
LEGN
$3.68B
$367K 0.07%
9,000
-1,000
-10% -$46.9K
BNTX icon
95
BioNTech
BNTX
$23.3B
$364K 0.07%
2,700
+500
+23% +$76.4K
SNY icon
96
Sanofi
SNY
$103B
$338K 0.07%
8,900
-2,884
-24% -$129K
NBIX icon
97
Neurocrine Biosciences
NBIX
$16.7B
$324K 0.06%
3,050
– –
JSPR icon
98
Jasper Therapeutics
JSPR
$20.2M
$316K 0.06%
40,000
-31,536
-44% -$577K
SRPT icon
99
Sarepta Therapeutics
SRPT
$1.68B
$310K 0.06%
2,800
– –
JAZZ icon
100
Jazz Pharmaceuticals
JAZZ
$15.8B
$263K 0.05%
1,970
– –
1 2 3
4
5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return
BIS
BG Investment Services Hagatna, Guam $120M AUM 17.44% 1-Year Est. Return

Sectoral Asset Management's Q3 2022 Portfolio in Review

As of Q3 2022, Sectoral Asset Management held 122 positions worth $508M, up 2.3% from $496M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Sectoral Asset Management's Q3 2022 filing shows 10 new, 33 increased, 37 reduced and 13 closed positions. Its largest new stake was CTI BioPharma Corp. (DE) Common Stock: 968,300 shares worth $5.64M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $9.2M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 96% a quarter earlier, followed by Industrials.

  • Sectoral Asset Management's largest Q3 2022 buy was CTI BioPharma Corp. (DE) Common Stock: 968,300 shares worth $5.64M.
  • Sectoral Asset Management added most to iRhythm Holdings in Q3 2022, an estimated $4.03M increase.
  • Sectoral Asset Management's biggest Q3 2022 reduction was Silk Road Medical, Inc. Common Stock, cutting an estimated $4.85M.
  • Sectoral Asset Management fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $9.2M.
  • Sectoral Asset Management's ten largest holdings make up 26% of its $508M portfolio in Q3 2022.
  • Sectoral Asset Management opened 10 new positions and closed 13 in Q3 2022.
  • Sectoral Asset Management's portfolio value rose 2.3% quarter-over-quarter to $508M.

Based on Sectoral Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.